PharmaResearch214450
PharmaResearch (214450) Preliminary Earnings, Nov 6, 2026
Filing date ·
PharmaResearch reported preliminary Q3 2026 results (consolidated): Revenue of KRW 171.5 billion (+26.7% year over year), operating profit of KRW 62.6 billion…
Sign in to read this filing in detail
Continue to the filing details and any available analysis after signing in.
Filing lists and official source links are available without signing in.